Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 5, 2013, Pages 398-405

  Wang, Chaochen ^a   Yatsuya, Hiroshi ^a,b   Tamakoshi, Koji ^c   Uemura, Mayu ^a   Li, Yuanying ^a   Wada, Keiko ^d   Yamashita, Kentaro ^a   Kawaguchi, Leo ^a   Toyoshima, Hideaki ^e   Aoyama, Atsuko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e ANJO KOSEI HOSPITAL   (Japan)

Author keywords

Cohort study; Hs CRP; Incidence; Overweight; Smoking status; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GOVERNMENT; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; WEIGHT;

COHORT STUDY; HS-CRP; INCIDENCE; OVERWEIGHT; SMOKING STATUS; TYPE 2 DIABETES;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; SUBURBAN HEALTH; URBAN HEALTH;

EID: 84880016837     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2406     Document Type: Article

References (55)

1. Sarwar N, Gao P, Seshasai SRK, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375(9733): 2215-2222.
2. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375(9709): 132-140.
3. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347(20): 1557-1565.
4. Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19(12): 3071-3078.
5. Arima H, Kubo M, Yonemoto K, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol 2008; 28(7): 1385-1391.
6. Cho DY, Kim KN, Kim KM, et al. Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in Korean population. Chin Med J 2012; 125(4): 569-573.
7. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3): 499-511.
8. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2003; 52(7): 1799-1805.
9. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-334.
10. Laaksonen DE, Niskanen L, Nyyssonen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004; 47(8): 1403-1410.
11. Snijder MB, Dekker JM, Visser M, et al. Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care 2003; 26(5): 1656-1657.
12. Lee CC, Adler AI, Sandhu MS, et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009; 52(6): 1040-1047.
13. Xu Y, Zhao Z, Li X, et al. Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine 2011; 39(2): 175-181.
14. Thorand B, Lowel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 2003; 163(1): 93-99.
15. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51(5): 1596-1600.
16. Bertoni AG, Burke GL, Owusu JA, et al. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2010; 33(4): 804-810.
17. Doi Y, Kiyohara Y, Kubo M, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care 2005; 28(10): 2497-2500.
18. Hu G, Jousilahti P, Tuomilehto J, et al. Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a Prospective Finnish Study. J Clin Endocrinol Metab 2009; 94(6): 2099-2105.
19. Nakanishi S, Yamane K, Kamei N, et al. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 2003; 26(10): 2754-2757.
20. Dehghan A, Kardys I, de Maat MP, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007; 56(3): 872-878.
21. Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25(11): 2016-2021.
22. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001; 50(10): 2384-2389.
23. Borissova AM, Tankova T, Kirilov G, et al. The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. Diabetes Metab 2004; 30(2): 147-152.
24. Attvall S, Fowelin J, Lager I, et al. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993; 233 (4): 327-332.
25. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003; 41(6): 1044-1047.
26. Zhang L, Curhan GC, Hu FB, et al. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2011; 34(4): 892-897.
27. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298(22): 2654-2664.
28. Thorand B, Baumert J, Kolb H, et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007; 30(4): 854-860.
29. Olafsdottir IS, Gislason T, Thjodleifsson B, et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60(6): 451-454.
30. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282(22): 2131-2135.
31. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
32. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54(6): 1027-1037.
33. Iso H, Cui R, Date C, et al. C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis 2009; 207(1): 291-297.
34. Matsushita K, Murohara T, Yatsuya H, et al. We are on the way to finding the cutoff point for high-sensitivity C-reactive protein in Japanese. Circ J 2007; 71(9): 1502.
35. Matsushita K, Yatsuya H, Tamakoshi K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007; 71(6): 820-825.
36. Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008; 9(Suppl 1): 53-61.
37. Wada K, Yatsuya H, Ouyang P, et al. Self-reported medical history was generally accurate among Japanese workplace population. J Clin Epidemiol 2009; 62(3): 306-313.
38. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-419.
39. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2012.
40. Chongsuvivatwong V. epicalc: epidemiological calculator. 2012
41. Therneau T. A package for survival analysis in S. 2012
42. Nakanishi N, Yoshida H, Matsuo Y, et al. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 2002; 45(1): 42-48.
43. Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 2007; 50(12): 1115-1122.
44. Obisesan TO, Leeuwenburgh C, Ferrell RE, et al. C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity. Metabolism 2006; 55(4): 453-460.
45. Zee RY, Germer S, Thomas A, et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 2008; 197(2): 931-936.
46. Wolford JK, Gruber JD, Ossowski VM, et al. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 2003; 78(2): 136-144.
47. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404(6779): 787-790.
48. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995; 44(4): 369-374.
49. Lim S, Lee HK, Kimm KC, et al. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome. Diabetes Res Clin Pract 2005; 70(2): 126-133.
50. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102(18): 2165-2168.
51. Wang G, Liu Y, Wang A, et al. Biomarkers of inflammation, endothelial dysfunction and insulin resistance in adults of Inner Mongolia, China. Diabetes Metab Res Rev 2010; 26(6): 490-495.
52. Huang X, Zhang J, Liu J, et al. C-reactive protein promotes adhesion of monocytes to endothelial cells via NADPH oxidase-mediated oxidative stress. J Cell Biochem 2012; 113(3): 857-867.
53. Pfutzner A, Standl E, Strotmann HJ, et al. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clin Chem Lab Med 2006; 44(5): 556-560.
54. Ishii S, Karlamangla AS, Bote M, et al. Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PLoS One 2012; 7(4): e36062.
55. Yamada S, Gotoh T, Nakashima Y, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153(12): 1183-1190.